June 23, 2017 / 12:36 PM / 2 months ago

BRIEF-Bayer gets positive CHMP opinion for regorafenib

June 23 (Reuters) - BAYER AG:

* ‍BAYER RECEIVES POSITIVE CHMP OPINION FOR REGORAFENIB FOR SECOND-LINE SYSTEMIC TREATMENT OF LIVER CANCER​

* ‍FINAL DECISION OF EUROPEAN COMMISSION ON MARKETING AUTHORIZATION IS EXPECTED IN COMING MONTHS​ Source text - bit.ly/2sYvWer Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below